hyperthyroidism. Hyperthyroidism NOS
Conditions
Interventions
Intervention 1: methimazole (20mg) is administered to the patients for 2 months. Intervention 2: in this study, primary serum level of prolactine before the initiation of metimazole administration is
Treatment - Drugs
methimazole (20mg) is administered to the patients for 2 months.
in this study, primary serum level of prolactine before the initiation of metimazole administration is considered as the control value. no drug/placebo group is defined for this study.
Sponsors
Vice chancellor for Research and Technology of kerman University of Medical Sciences, Physiology res
Eligibility
Sex/Gender
Female
Age
15 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria:Women with hyperthyroidism; Age between 15 to 50 years Exclusion criteria : use of drugs which increase prolactine level: dopamine receptor blocker including phenotiazine,chlorpromazin,perfenazine,butirofenon,haloperidole,thioxantine,metocloperamide ; dopamin synthesis inhibitor(etc. methyldopa) ;cathecolamin releasing agent: reserpin; Opiates ;H2 blockers including cimetidin,ranitidin; Imipramin,Amitriptylin; serotonin intake inhibitor:Fluoxetin; Calcium channel blockers:Verapamil; hormones: Estrogens;Antiandrogens,TRH; Others:pregnancy,lactation,liver disease,chronic kidney disease.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum prolactine level. Timepoint: Pre-treatment; post-treatment. Method of measurement: ICMA. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Mojgan Sanjari
Kerman afzalipour hospital
Outcome results
None listed